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Recently, small RNA molecules known as microRNAs (miRs), composed of 20 -24 nucleotides and located in the exons or introns of many genes, have received considerable attention because of their ability to regulate gene function at the posttranscriptional level by either blocking protein translation and/or by modulating mRNA stability. The importance of miRs in skeletal metabolism became obvious from a study that showed that osteoblast-specific conditional deletion of Dicer, a factor involved in the processing of precursor miR into mature miR, resulted in a high bone mass phenotype (9) . Subsequently, a number of miRs including miR214 (31) , miR142-3p (16) , miR218 (14) , miR100 (35) , miR764-5p (12) , miR22 (17) , miR17 (13, 24) , miR20a (37) , and miR637 (36) have been implicated in regulating osteoblast cell functions based on in vitro findings. However, the issue of whether the miRs expressed in osteoblast lineage cells exert a significant physiological role in regulating the bone formation process has not been elucidated.
In this study, we evaluated the role of the miR17-92 cluster, a genomic region that contains six miRs (17, 18a, 19a, 20a, 19b , and 92a), in bone metabolism. We chose the miR17-92 cluster for this study based on a recent report demonstrating that individuals with haploid insufficiency of the miR17-92 cluster show digital abnormalities, in particular shortening of the mesophalanx of the fifth finger, short stature, and microcephaly (5) . Consistent with the clinical data, mice with targeted deletion of both copies of miR17-92 cluster in all cell types exhibited digit anomalies as evident from skeletal staining in embryonic day 18.5 embryos (5). However, since total knockout of miR17-92 resulted in premature death, the role of the miR17-92 cluster in postnatal skeletal development could not be determined. We, therefore, utilized a conditional knockout (cKO) approach to evaluate the role of miR17-92 cluster expressed in osteoblast lineage cells on postnatal skeletal growth.
MATERIALS AND METHODS

miR Quantization in Bones of IGF-I cKO Mice
IGF-I floxed mice were crossed with type I collagen Cre mice to generate IGF-I cKO and corresponding wild-type (WT) control mice as described (22) . Total RNA was isolated from 12 wk old tibias of IGF-I cKO and WT mice with Trizol reagents. The miR-specific reverse transcription (RT) primer, RT-related chemicals, miR-specific real-time polymerase chain reaction (PCR) primer, and Taqman master mix were purchased from Applied Biosytems (Carlsbad, CA). We subjected 10 ng of total RNA to miR RT followed by real-time PCR according to the manufacturer's instructions (Applied Biosystems). We used miR15b for in vivo study and for in vitro study miRU6 as internal controls to normalize the expression levels of targets. Data were expressed as fold changes vs. WT mice.
miR Quantization in Response to IGF-I in Bone Cells
Serum-free MC3T3 osteoblast and ATDC5 chondrocyte cells lines were treated with or without 100 ng/ml IGF-I as described earlier (22, 33) . The study was terminated after 24 or 72 h. Total RNA was isolated with Trizol reagents according to the manufacturer's instructions (Invitrogen, Carlsbad, CA), and miR levels were measured in the IGF-I vs. vehicle-treated cells.
Generation of miR17-92 Cluster cKO Mice
Breeding pairs of transgenic mice in which Cre recombinase is driven by the entire regulatory region of the procollagen Type 1 ␣2 gene (Col1␣2-Cre, available in-house) were bred with transgenic mice, in which the miR17-92 cluster is flanked by loxP sites (miR17-92 loxPϩ/ϩ mice were purchased from Jackson Laboratory) to generate Creϩ loxPϩ/Ϫ and CreϪ loxPϩ/Ϫ mice in the F1 generation. In the F2 generation, we crossed Creϩ loxPϩ/Ϫ mice with CreϪ loxPϩ/ϩ transgenic mice to generate Creϩ miR17-92 loxPϩ/ϩ (homozygous cKO) and the littermate control CreϪ miR17-92 loxPϩ/ϩ WT mice for our studies (see Fig. 2A ). In the past, we have carefully examined Col1␣2 and iCre expression in various tissues. We found iCre expression is high in Col1␣2-expressing cells such as osteoblast and absent in other cell types such as liver and brain. We, therefore, chose iCre driver to efficiently knockdown the miR17-92 cluster in osteoblast lineage cells. However, since there is also some Col1␣2 and iCre expression in muscle and heart, albeit at low levels, the iCre line used is not entirely specific to osteoblasts (11) . The experimental procedures performed in this study were approved by the Institutional Animal Care and Use Committee at Loma Linda Health Care System (VALLHCS).
Genotyping of Cre/loxP Mice
When the mice were 3 wk of age, we extracted DNA from tail tissue using a PUREGENE DNA Purification Kit (Gentra Systems, Minneapolis, MN) according to the manufacturer's protocol, followed by PCR to differentiate the genotypes. We used Cre-recombinase primers: forward 5= TTA GCA CCA CGG CAG CAG GAG GTT 3= and reverse 5=-CAG GCC AGA TCT CCT GTG CAG CAT-3= and miR17-92 loxP primers: forward-5= TCG AGT ATC TGA CAA TGT GG-3= and reverse 5=-TAG CCA GAA GTT CCA AAT TGG-3= for the genotyping. PCR was performed using appropriate forward and reverse primers and Promega master mix as described previously (22) . The PCR products were run on a 1.5% agarose gel, stained with ethidium bromide, and visualized with the ChemiImager 4400 Low Light Imaging System (Alpha Innotech, San Leandro, CA).
miR Quantitation
Total RNA from bones cells of 5 wk old cKO and WT mice was isolated with Trizol reagents. miR levels were measured by real-time PCR in these samples as described above.
Bone Densitometry by Dual X-ray Absorptiometry
Total body bone mineral content (BMC), area, and areal bone mineral density (BMD) were measured at 2, 4, and 8 wk of age in both male and female cKO and WT mice by dual X-ray absorptiometry (DXA), using the PIXImus instrument (LunarCorp, Madison, WI). The precision for the BMC and BMD was Ϯ1% for repeat measurements of the same bones (11) . Measurements were carried out while the mice were under inhalable anesthesia (5% isoflurane and 95% oxygen). Mouse body weights and lengths were measured.
Micro-CT Measurements
Cortical (diaphysis) and trabecular (metaphysis and L5 vertebra) bone parameters were analyzed by microcomputed tomography (micro-CT), a high-resolution tomography image system (Scanco In vivo CT40) as previously described (22) . Since cKO mice were smaller compared with littermate WT mice, the sampling sites were adjusted for differences in bone length, so that the same sampling site could be used for the two genotypes. Parameters such as tissue volume (TV mm 3 ) , bone volume (BV, mm 3 ), bone volume fraction (BV/TV, %), cortical thickness (Ct.Th, mm), trabecular number (1/mm), trabecular thickness (mm), and trabecular separation (mm) were evaluated. The values presented in micro-CT figures represent the average of 100 slices for each parameter.
Mechanical Properties of Bone
Femurs from 12 wk female mice were stored at 4°C in gauze, moistened with 1ϫ PBS. Prior to analysis, the bones were thawed out and the anterior-posterior diameter (AP.Dm) and lateral-medial diameter (LM.Dm) were measured with calipers. Mechanical properties of the femurs were evaluated by three-point bending using the Instron DynaMight testing system (model 8840; Instron, Canton, MA) as previously described (20) . In brief, each femur was placed on two immovable supports that were 7 mm apart and an initial 1.0 N load was applied to the femur at the diaphysis to prevent rotation of the bone during breaking. Loads were then applied at the midpoint of the femur at a constant rate (5 mm/min) until the femur fractured. Load displacement curves were used to calculate the maximum load (P max), toughness (Ut), and slope (S) (32) . The cross-sectional moment of inertia was calculated from the measured AP.Dm and LM.Dm and from the average Ct.Th obtained from micro-CT analysis.
Histomorphometric Analysis
Male cKO and WT mice were injected with calcein (7.5 mg/kg of body wt) on postnatal day 22 followed by a second injection on day 29. Two days after the last injection, mice were euthanized and bones samples were collected and fixed in 10% formalin. Cortical parameters such as total area (TA mm), periosteal bone formation rate (Ps. BFR mm 2 ϫ 10 Ϫ3 /day) and mineral apposition rate (MAR, m/day), endosteal bone formation rate (Ec. BFR mm 2 ϫ 10 Ϫ3 /day), and MAR m/day were calculated at the femur diaphysis in male WT and cKO mice as described (28) . Resorbing surface was measured by the amount of tartrate-resistant acid phosphatase (TRAP)-labeled surface (%) at the periosteal and endosteal sites in crosssectional samples (22) .
Periosteal Tissue RNA Extraction and Gene Expression Analysis
Total RNA was isolated from the periosteal tissue of marrow intact tibias of WT and cKO mice with Trizol. In brief, marrow intact bones were immersed in 500 l of Trizol for a short duration (30 min) on ice with a gentle vortex every 5 min. Since Trizol is acidic, a short duration of incubation results in the detachment of primarily periosteal cells, while a longer incubation period results in detachment of cells from both periosteum as well as from bone. Therefore, we chose shorter incubation period for the study. Furthermore, to validate that the isolated cells were periosteal cells, we evaluated periostin levels, a marker for periosteal cells by real-time RT-PCR. After the incubation period, bones were removed and total RNA was isolated from Trizol solution with a kit from Zymo Research according to the manufacturer's instructions (22) . The quality and quantity of RNA were analyzed with the 2100 Bio-analyzer (Agilent, Palo, Alto, CA) and Nano-Drop (Wilmington, DE). Purified total RNA (200 g/l) was used to synthesize the first-strand cDNA by reverse transcription according to the manufacturer's instructions (Bio-Rad). Quantitative real-time RT-PCR was used to determine the expression levels of genes as previously described (21, 22). Gene-specific primers were designed with Vector NTI software and ordered from IDT DNA technologies (San Diego, CA). Data normalization was accomplished by using an endogenous control (␤-actin) to correct for variation in the RNA quality among samples. The normalized Ct values were used to calculate the fold change between the externally loaded and nonloaded groups using the 2 Ϫ⌬⌬ Ct formula.
Mechanical Strain Calculation
We measured cross-sectional area and moment of inertia at a cortical site of the tibia (3 mm away from the tibia-fibular junction) in both male and female cKO and WT mice by in vivo peripheral quantitative computed tomography (pQCT) as described earlier (21, 22) . This pQCT data was used for mathematical evaluation of mechanical strain as described (21, 23) .
In vivo Mechanical Loading
To stimulate periosteal bone formation in the mouse model, we performed mechanical loading using a four-point bending device (Instron, Canton, MA) as previously reported (21, 27) . Adjusted loads were applied to both male and female cKO and WT mice at a frequency of 2 Hz for 36 cycles, once a day under inhalable anesthesia (4% isoflurane and 95% oxygen) for a period of 2 wk (6 days/wk with 1 day rest). The right tibia was used for loading and the left tibia was used as an internal nonloaded control. Forty-eight hours after the last day of loading, bones were collected and used for evaluation of loading induced changes using micro-CT as described (22) .
Statistical Analyses
Data are presented as means Ϯ SE. The values are expressed as absolute values or as percentage changes in the cKO vs. WT mice for the various phenotype measurements. We used three-way ANOVA for the DXA data analyses and standard t-test for gene expression, bone breaking, and micro-CT analysis. The differences were considered statistically significant at P Ͻ 0.05. SPSS (version 21) statistical software was used to perform the analyses.
RESULTS
IGF-I Regulation of miRs
To identify the downstream targets of IGF-I, we evaluated expression levels of selected miRs that have been implicated to play a role in bone metabolism in tibias of IGF-I cKO and WT mice. Quantitative analysis revealed that expression levels of miR92a, miR20a, miR16, miR146a, and miR222 were altered by two-to eightfold (P Ͻ 0.05) in the bones of mice with disruption of IGF-I gene in type I collagen-expressing osteoblast compared with corresponding WT mice (Fig. 1A) . Accordingly, serum-free MC3T3 osteoblast cells treated with 100 ng/ml of IGF-I showed increased expression levels of miR20a and miR146a by two-and sevenfold, respectively at 24 h (Fig.  1B) , while miR93 was decreased by twofold at 72 h (Fig. 1C) . To determine if IGF-I mediated changes in expression levels of miRs in chondrocytes, we evaluated expression levels of these miR in serum-free cultures of ATDC5 chondrocytes after treatment with 100 ng/ml of IGF-I or vehicle. We found miR93 expression was increased by 1.5-fold (P Ͻ 0.05), while changes in miR20a and miR15b levels were not statistically significant (Fig. 1D) . Because expression levels of miRs in the miR17-92 cluster were regulated by IGF-I treatment in osteoblasts both in vitro and in vivo and because targeted knockout of miR17-92 cluster affected skeletal development, we focused on miR17-92 in this study.
Generation of cKO Mice and Cluster Deletion Validation
Mice with a global deletion of the miR17-92 cluster could not be used for studies on the role of the miR17-92 cluster on postnatal bone growth as these mice die immediately after birth from lung hypoplasia and ventricular septal defects (5). Therefore, to test the role of the miR17-92 cluster specifically expressed in osteoblasts, we generated osteoblast-specific cKO mice via a Cre-loxP approach ( Fig. 2A) . To validate the 1.1 kb A P Ͻ 0.01 vs. WT, n ϭ 6 for in vivo data and n ϭ 3 for in vitro data. miR17-92 cluster deletion in the cKO mice, we evaluated expression levels of two miRs from the cluster by real-time RT-PCR on bone cell RNA isolated from 5 wk old WT and cKO mice. Figure 2B shows that expression levels of miR20a and miR92a from the cluster were reduced by 70% (P Ͻ 0.01) in the cKO mice, while expression levels of two other miRs that are not located in the miR17-92 cluster were unaltered compared with WT mice.
Whole Body DXA Measurements in the cKO and WT Mice
To investigate if knock down of the miR17-92 cluster in cells of the osteoblast lineage influences postnatal skeletal growth in vivo, we evaluated the skeletal phenotype by DXA in both male and female mice. In contrast to global deletion, mice with conditional disruption of the miR17-92 cluster in type I collagen-expressing cells were born normally and survived to adulthood. However, body weight was reduced significantly (15-25%) at 2, 4, and 8 wk of age in both sexes. Total body length was reduced by 8 -10% in the cKO mice of both sexes. DXA analysis revealed significant reductions in total body BMC (15-30%) and bone area (13-30%) in the cKO mice of both sexes at 2, 4, and 8 wk ( Table 1 ). The small reduction in total body BMD (Ͻ5%) in the cKO mice was not consistent across all ages (Table 1) .
Interaction analysis by ANOVA revealed that the genotypesex interaction for total body BMC and bone area was not statistically significant, indicating that the miR17-92 cluster affects the skeleton in a similar pattern in both sexes. However, the genotype effect on total body BMC and bone was age dependent (Table 1) .
Micro-CT Measurements of Cortical and Trabecular Parameters in the cKO and WT Mice
Cortical bone. Micro-CT analysis of skeletal parameters in male (Fig. 3, A-F) and female (Fig. 3 , G-L) mice at the femur diaphysis revealed a 20 -27% reduction in TV, a 17-21% reduction in BV, but no change in BV/TV or Ct.Th in the cKO mice when compared with WT mice. Similarly, tibia bones also showed a 14 -20% reduction in TV and BV but no significant difference in BV/TV or Ct.Th in the cKO mice compared with WT mice (data not shown). Consistent with the total body length, femur length was reduced by 6 -8% in the male and female cKO mice compared with WT mice (Fig. 3,  A-F, and G-L) . The difference in TV was still significant (P Ͻ 0.05) even after we adjusted for bone length differences between the two genotypes (data not shown).
Trabecular bone. Micro-CT analysis of trabecular bone parameters at the femoral metaphysis revealed a 25% reduction in TV in the cKO mice compared with WT mice. While BV was reduced by 17% in the cKO mice, this reduction was not significant. Trabecular BV/TV or other trabecular parameters (number, thickness, and separation) were not significantly different between the two genotypes (Fig. 4, A-G) . In addition to the femur metaphysis, we also measured trabecular bone parameters in L5 lumbar of vertebra in the cKO mice. We found no significant difference in any of the trabecular bone Values are means Ϯ SE. DXA, dual X-ray absorptiometry; cKO, conditional knockout; BMC, bone mineral content; BMD, bone mineral density. Male: n ϭ 7 (2 wk), n ϭ 10 (4 wk), and n ϭ 6 -7 (8 wk).
A P Ͻ 0.05 vs. wild-type (WT) mice, #P ϭ 0.08 vs. WT. Female: n ϭ 6 (2 wk), n ϭ 10 -11 (4 wk), n ϭ 5-7 (8 wk),
A P Ͻ 0.05 vs. WT mice.
parameters (BV/TV, number, thickness, and separation) between the two genotypes (Fig. 4, H-M) .
Mechanical Properties of Cortical Bone in the Femur of cKO and WT Mice
To determine if the decrease in bone size (reduced TV at the diaphysis and metaphysis) in the cKO mice leads to reduced bone strength, we measured bone breaking strength with a three-point bending technique at the middiaphysis of the femurs derived from 12 wk old female WT and cKO mice. Figure 5 shows that the ultimate breaking strength (P max ) was reduced by 10% (P Ͻ 0.05) in cKO mice compared with WT mice. However, there was no significant difference in Ut or S between the cKO and WT mice (Fig. 5) .
Histomorphometric Analysis of Cortical Bone in the cKO and WT Mice
Histomorphometric measurements at the middiaphysis of the femur revealed that total area (tissue area) was reduced by 20% in cKO compared with WT mice (Fig. 6A) . Similarly, the marrow area was also reduced to a similar magnitude in cKO mice (WT 1.08 Ϯ 0.008, KO 0.86 Ϯ 0.006; P Ͻ 0.05). The periosteal (Fig. 6B ) and endosteal BFR (Fig. 6E) were reduced by 28 and 36% (P Ͻ 0.05) in cKO mice compared with WT mice. A similar reduction in the MAR was found at both periosteal and endosteal sites of the cKO mice compared with WT mice (Fig. 6, C and F) . While the resorbing surface, measured by % TRAP-labeled surface, was slightly reduced at both periosteal and endosteal sites of the cKO mice, these reductions were not statistically significant (Fig. 6, D and G) .
Expression Levels of miR17-92 Targeted Genes in the cKO and WT Mice
MiRs in the miR17-92 cluster targeted a number of mRNAs as predicted by miR target prediction software. Of these potential miR17-92 targets, we choose six candidates with known functions in osteoblasts to determine if expression levels of one or more of these targets were influenced by targeted deletion of the miR17-92 cluster in osteoblasts. Quantitative analysis by real-time RT-PCR revealed 25-28% reductions in the expression levels of periostin, Runx2, and Elk3 in the periosteal tissue of cKO mice compared with WT mice. By contrast, expression levels of Tbx20, Nek6, and VEGFC were unaffected by miR17-92 cluster deletion in osteoblasts (Fig. 7) .
Mechanical Loading and miR20a Expression
Since mechanical loading is an important physiological regulator of periosteal bone formation, we next determined if mechanical loading effects on periosteal expansion is mediated in part via modulation of miR17-92 cluster expression in osteoblasts. We, therefore, evaluated the expression level of miR20a and miR92a, two of the miR from the cluster, after 2 wk of four-point bending in the loaded and unloaded tibia of good-responder C57BL/6J mice. We focused on these two miRs since only miR20a and miR92a were found to be expressed in osteoblasts and since previous studies have implicated involvement of these two miRs in mediating the osteogenic effects of bone formation regulators in vitro (26, 37) . Quantitative analysis by real-time RT-PCR revealed a 1.3-fold in miR92a (P ϭ 0.15) and 2.1-fold increase (P Ͻ 0.05) in miR20a levels in the loaded tibia compared with the unloaded tibia (Fig. 8A) . Subsequently, we also performed correlation analysis between changes in levels of miR20a vs. Runx2, periostin, and Elk3 in response to mechanical loading. Although changes in miR20a levels correlated positively with Runx2 (r ϭ 0.65, P ϭ 0.07), periostin (R ϭ 0.35, P ϭ 0.43), and Elk3 (R ϭ 0.31, P ϭ 0.49), none of these associations was statistically significant. Thus, additional replicates are necessary to confirm the significance of these associations. Since mechanical loading was applied through four-point bending, which mainly affects periosteal surface, we presume that the obtained changes in the expression levels of miRs were due to changes in periosteal cells, which need to be examined experimentally in future work.
Bone Anabolic Response to Mechanical Loading in the cKO and WT Mice
We next determined if loss of the miR17-92 cluster in osteoblasts influences the mechanical loading effect on periosteal bone formation by evaluating the periosteal bone response to mechanical loading by four-point bending in the cKO and WT mice. Since female cKO mice showed a 27% (P Ͻ 0.05) reduction in TV compared with that of WT mice, we predicted that mice with bones of smaller circumference would tend to receive higher mechanical strain than mice with bones of a larger circumference at a given load. To assure that the difference in skeletal anabolic response to loading is due to a lack of --------------------------------------------------------------- miR expressed from the osteoblast miR17-92 cluster and not due to differences in mechanical strain contributed by bone size differences, bone mechanical strain was calculated by a mathematical model for varying loads (6-, 7-, 8-, and 9 N) using the geometrical data obtained from pQCT in female mice. The calculated data show that a 7 N load (4,717 Ϯ 460 ⑀, n ϭ 5) in the female cKO mice produced mechanical strain equivalent to a 9 N load (4,555 Ϯ 454 ⑀, n ϭ 7) in the WT female mice. On the basis of these calculated mechanical strain data, we applied adjusted loads on the tibias of both male and female cKO and WT mice using a four-point bending device such that both sets of mice received a similar amount of mechanical strain. We chose the four-point bending method of loading since we and others have shown that this model induced a robust periosteal bone formation (1, 21) . In response to 2 wk of four-point bending, the loaded tibia of WT female mice showed 15-40% increases in bone parameters such as TV, BV, BV/TV, and Ct.Th compared with unloaded tibias (Fig. 8, B-G) . By contrast, there was no significant increase in any of these parameters in the loaded region of cKO mice compared with unloaded tibia.
DISCUSSION
The findings of this study demonstrate that a targeted deletion of the miR17-92 cluster in type I collagen-expressing osteoblasts reduced longitudinal growth as well as bone size, which contributed to the observed changes in total body bone area in cKO mice compared with WT mice. The reduced total body BMC in cKO mice is mainly due to reduced bone area as total body BMD was unchanged in the cKO mice. Consistent with the DXA data, micro-CT measurements revealed no significant difference in BV/TV at a cortical or trabecular site in cKO mice. Consistent with our data, a previous study demonstrated that universal disruption of the miR17-92 cluster resulted in smaller embryos that died immediately after birth due to hypoplastic lungs and ventricular septal defects in the heart (5). Although mice with conditional disruption of the miR17-92 cluster in type I collagen-expressing cells were smaller compared with corresponding WT littermate controls, they survived to adulthood. These data suggest that the miR17-92 cluster regulates growth of the multiple tissues during embryonic and postnatal growth.
Time course studies revealed that both total body bone area as well as bone mass were decreased significantly in both sexes as early as 2 wk (P Ͻ 0.05, 3-way ANOVA main effects) in mice with targeted KO of the miR17-92 cluster in type I collagen-expressing osteoblasts. The magnitude of reduction in bone area and BMC in the cKO mice persisted until the end of the study. In contrast to our study, Zhou et al. (38) report that mice with haploid insufficiency of the miR17-92 cluster showed a reduction in bone mass at 8 wk but not at 4 wk of age. In this study, one copy of the miR17-92 cluster was disrupted by crossing miR17-92 floxed mice with actin-Cre mice. Since actin is expressed universally, heterozygous miR17-92 floxed mice that are Cre positive will have one copy of the miR17-92 cluster disrupted in all actin-expressing cells. In this study, the reduced bone mass in 8 wk old heterozygous miR17-92 cluster KO mice appears to be caused by reduced total body BMD rather than bone area. In terms of observed differences in the phenotype between our study and that of Zhou et al. (38) , there are important differences in the two genetic mouse models that need to be considered. First, the actin promoter driven Cre is likely to disrupt the miR17-92 cluster in all bone cell types (osteoblasts, chondroblasts, osteoclasts) as well as in other cell types, while the Cre driver used in the current study disrupts the miR17-92 cluster in type I collagen-expressing osteoblasts. Second, while a single copy of the miR17-92 cluster was knocked down in the haploid insufficient mouse model, both copies of the miR17-92 cluster were disrupted in our conditional KO mouse model. Thus, loss of the miR17-92 cluster in type I collagen-expressing cells exerted skeletal changes early that were greater in magnitude compared with the loss of single copy of miR17-92 cluster universally. Future studies are needed to address if the observed difference in the BMD phenotype between the two mouse models can be explained on the basis of differences in the cell types in which the miR17-92 cluster is disrupted. While bone mass increased with age as expected in both sexes with greater increases in male mice than female mice after puberty, there was no sex-genotype interaction for any of the skeletal parameters. Similarly, no sex difference was reported in the skeletal phenotype of heterozygous miR17-92 cluster mice (38) . Based on the finding that conditional disruption of miR17-92 cluster in osteoblasts led to a significant reduction in bone mass in prepubertal mice and that the skeletal phenotype difference between cKO and WT mice was maintained through puberty, it can be concluded that the miR17-92 cluster effect on osteoblast functions is not dependent on sex hormones.
Surprisingly, disruption of the miR17-92 cluster in type I collagen-expressing osteoblasts influenced longitudinal growth. In this regard, it is generally accepted that the proliferating and differentiating chondrocytes at the growth plate predominantly contribute to longitudinal growth. Since type I collagen is not known to be expressed in chondrocytes, it is not likely that miR17-92 cluster expression in chondrocytes is affected in cKO mice. Therefore, we speculate that the reduced femur and tibia length in the cKO mice is a consequence of disruption of osteoblast actions. In this regard, we previously demonstrated that disruption of IGF-I in osteoblasts lead to a dramatic reduction in longitudinal growth (10) . Accordingly, we found that expression levels of miRs in the miR17-92 cluster were regulated by IGF-I, thus suggesting that the IGF-I effect on longitudinal growth may in part be mediated via IGF-I regulation of miR17-92 expression. Furthermore, disruption of ephrinB1 in osteoblasts decreased femur length (34) . These findings are consistent with a model in which osteoblasts actions also contribute to longitudinal growth. It remains to be determined if disruption of the miR17-92 cluster in osteoblasts leads to alterations in the production of paracrine factors that target chondrocytes and, thereby, influence longitudinal growth.
The major phenotype in cKO mice appears to be on bone size as revealed by micro-CT and histomorphometric analyses of long bones. Bone size is reduced by nearly 20 -27% in cKO mice compared with WT mice. In terms of identifying mechanisms for reduced periosteal expansion in the cKO mice, we found that the Ps. BFR was significantly reduced in cKO compared with WT mice. By contrast, bone resorption at the periosteum as measured by the TRAP-labeled surface was not significantly increased in the cKO mice. These data suggest that the miR17-92 cluster miRs expressed in osteoblasts primarily influence bone formation. It remains to be determined if osteoclasts also express one or more of the miRs in the miR17-92 cluster and, if so, if these miRs influence formation and/or activity of osteoclasts.
In terms of cellular mechanisms for reduced bone formation at the periosteum, we found that MAR was reduced to a similar magnitude as that of the BFR in cKO mice. By contrast, the calcein labeled forming surface, a marker of osteoblast number, was not significantly different between the two genotypes. Since MAR is a measure of osteoblast activity, our data suggest that lack of miR17-92 cluster influences differentiated functions of osteoblasts. Consistent with this interpretation, Zhou et al. (38) report that osteoblasts-derived from heterozygous miR17-92 conditional KO mice showed lower ALP activity and formed less mineralized nodules in vitro. These data are consistent with the possibility that miR17-92 cluster influences osteoblast differentiation or its activity and, thereby, influences bone formation. In terms of how the miR17-92 cluster could influence osteoblast differentiation, we found that the expression levels of Runx2 and periostin were significantly reduced in the periosteal tissue of cKO mice compared with WT mice. Both Runx2 and periostin are identified as targets for miRs expressed in the miR17-92 cluster and have been shown to play critical role in osteoblast differentiation (15, 37) . In fact, periostin is highly expressed in periosteal cells (19) , and reduced bone size is key feature of mice with a targeted KO of periostin. Future studies will address the possibility that the miR17-92 cluster affects osteoblast differentiation through regulation of periostin and/or Runx2 expression.
Because the periosteal bone formation rate was reduced in cKO mice and because mechanical strain has been shown to be an important physiological regulator of periosteal bone formation, we predicted that the miR17-92 cluster, may, in part, mediate the mechanical strain effect on periosteal cell functions during postnatal growth. In support of this prediction, we found that the expression level of miR20a was increased in the loaded bones compared with unloaded bones. Furthermore, we found that the increased periosteal bone response to 2 wk of four-point bending of the tibia as measured by changes in TV and BV/TV by micro-CT failed to occur in the cKO mice. By contrast, bones of WT mice loaded with same amount of mechanical strain showed robust periosteal bone response. These data provide a direct demonstration that the miR17-92 cluster, expressed in osteoblasts, is critically involved in mediating the mechanical strain effect on bone cells. Future studies are needed to address the mechanism by which mechanical strain influences expression of the miR17-92 cluster targets.
In our expression studies, we chose to focus on miR20a and miR92a based on the following rationale. First, Zhou et al. (38) have reported that while expression levels of miR20a and miR92a were regulated during osteoblast differentiation, none of the other four miRs in the 17-92 cluster (i.e., miR17, miR18a, miR19a, and miR19b) was found at detectable level either in proliferating or differentiating osteoblasts. Second, in vitro studies have shown a role for miR20a and miR92a in mediating bone morphogenetic protein effects on osteogenic differentiation (25, 37) . We, therefore, evaluated expression levels of miR20a and miR92a and found that expression levels of both of these miRs were downregulated significantly in the bones due to loss of IGF-I, suggesting that these miRs are in part regulated by IGF-I. To test the direct effect of IGF-I, we treated osteoblast cells with IGF-I and found that only miR20a was increased significantly. We have not examined the IGF-I effect on miR92a expression in different stages of osteoblast differentiation or in other bone cell types (chondrocytes and osteoclasts).
Some of the limitations in this study are as follows: 1) we have shown that the miR17-92 cluster affects the skeleton in a similar pattern in growing mice. However, the issue of whether the miR17-92 cluster contributes to sex-related difference in skeletal parameters in older age groups of mice needs further study. 2) An earlier study using an in vitro model has shown that miR17-5p, miR20a, and miR92a are highly expressed compared with other miRs in the cluster by osteoblast cells (38) . While our study also shows that miR20a and miR92a are expressed in periosteal cells, it remains to be determined which of the miRs in the cluster contributes to the observed skeletal changes in the miR cKO mice.
3) The Cre driver used in this study is not entirely specific to osteoblasts as it also drives Cre expression in certain types of connective tissue cells that also produce type I collagen. The issue of whether the miR17-92 cluster disruption in these connective tissues cells also contributes to the observed phenotype changes in the skeleton remains to be determined. 4) We anticipated the expression levels of miR17-92 targets to be increased in the miR17-92 cKO mice. However, that was not the case. One possibility is that they are not the direct targets. Further studies are needed to determine if the selected candidates are direct targets of miR17-92 and, if so, the mechanism for miR17-92 cluster regulation of the selected target genes. 5) While our expression data reveal a role for miR20a in mediating bone formation response to mechanical loading, further studies using mice with conditional disruption of miR20a alone in osteoblast lineage cell is necessary to test the direct role of miR20a in mediating skeletal anabolic response to mechanical loading. 6) Type I collagen is also expressed in bone marrow mesenchymal cells (7) . However, in this study, we have not specifically evaluated the relative contribution of miR17-92 cluster expressed in mesenchymal stem cells.
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